dalteparin and pyrazines

dalteparin has been researched along with pyrazines in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Alkan, M; Demirkol, MA; Dinc, V; Esatoglu, SN; Kamat, S; Kostek, ME; Sargin Altunok, E; Satici, C; Toprak, ID; Yazla, S1
Daye, M; Oltulu, P1

Other Studies

2 other study(ies) available for dalteparin and pyrazines

ArticleYear
Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave.
    Journal of medical virology, 2022, Volume: 94, Issue:1

    Topics: Aged; Amides; Antibodies, Monoclonal, Humanized; Azithromycin; C-Reactive Protein; Comorbidity; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Enoxaparin; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Male; Methylprednisolone; Middle Aged; Pyrazines; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Turkey

2022
An AGEP case due to COVÄ°D-19 or favipiravir or enoxaparin.
    Journal of cosmetic dermatology, 2022, Volume: 21, Issue:1

    Topics: Amides; COVID-19; Enoxaparin; Humans; Pyrazines; SARS-CoV-2

2022